Search details
1.
COR-101, ein menschlicher Antikörper gegen COVID-19.
Biospektrum (Heidelb)
; 27(1): 46-48, 2021.
Article
in German
| MEDLINE | ID: mdl-33612989
2.
Single Chain Antibodies as Tools to Study transforming growth factor-ß-Regulated SMAD Proteins in Proximity Ligation-Based Pharmacological Screens.
Mol Cell Proteomics
; 15(6): 1848-56, 2016 06.
Article
in English
| MEDLINE | ID: mdl-26929218
3.
MHC/Peptide-Specific Interaction of the Humoral Immune System: A New Category of Antibodies.
J Immunol
; 195(9): 4210-7, 2015 Nov 01.
Article
in English
| MEDLINE | ID: mdl-26416277
4.
Designing Human Antibodies by Phage Display.
Transfus Med Hemother
; 44(5): 312-318, 2017 Sep.
Article
in English
| MEDLINE | ID: mdl-29070976
5.
Selection of Recombinant Human Antibodies.
Adv Exp Med Biol
; 917: 23-54, 2016.
Article
in English
| MEDLINE | ID: mdl-27236551
6.
Generation of Recombinant Antibodies Against Toxins and Viruses by Phage Display for Diagnostics and Therapy.
Adv Exp Med Biol
; 917: 55-76, 2016.
Article
in English
| MEDLINE | ID: mdl-27236552
7.
Generation and analysis of the improved human HAL9/10 antibody phage display libraries.
BMC Biotechnol
; 15: 10, 2015 Feb 19.
Article
in English
| MEDLINE | ID: mdl-25888378
8.
Rekombinante, vollständig humane Antikörper zur Behandlung akuter COVID-19.
Biospektrum (Heidelb)
; 26(4): 444-446, 2020.
Article
in German
| MEDLINE | ID: mdl-32834543
9.
High level transient production of recombinant antibodies and antibody fusion proteins in HEK293 cells.
BMC Biotechnol
; 13: 52, 2013 Jun 26.
Article
in English
| MEDLINE | ID: mdl-23802841
10.
Novel NKG2D-directed bispecific antibodies enhance antibody-mediated killing of malignant B cells by NK cells and T cells.
Front Immunol
; 14: 1227572, 2023.
Article
in English
| MEDLINE | ID: mdl-37965326
11.
Evaluation of the Neutralizing Antibody STE90-C11 against SARS-CoV-2 Delta Infection and Its Recognition of Other Variants of Concerns.
Viruses
; 15(11)2023 Oct 25.
Article
in English
| MEDLINE | ID: mdl-38005829
12.
Identification of immunogenic proteins and generation of antibodies against Salmonella Typhimurium using phage display.
BMC Biotechnol
; 12: 29, 2012 Jun 15.
Article
in English
| MEDLINE | ID: mdl-22703709
13.
Phage display for the generation of antibodies for proteome research, diagnostics and therapy.
Molecules
; 16(1): 412-26, 2011 Jan 10.
Article
in English
| MEDLINE | ID: mdl-21221060
14.
Characterization of an In Vivo Neutralizing Anti-Vaccinia Virus D8 Single-Chain Fragment Variable (scFv) from a Human Anti-Vaccinia Virus-Specific Recombinant Library.
Vaccines (Basel)
; 9(11)2021 Nov 10.
Article
in English
| MEDLINE | ID: mdl-34835240
15.
Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and Therapy.
Front Cell Infect Microbiol
; 11: 697876, 2021.
Article
in English
| MEDLINE | ID: mdl-34307196
16.
A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutations.
Cell Rep
; 36(4): 109433, 2021 07 27.
Article
in English
| MEDLINE | ID: mdl-34273271
17.
Screening for scFv-fragments that are stable and active in the cytosol.
Hum Antibodies
; 28(2): 149-157, 2020.
Article
in English
| MEDLINE | ID: mdl-32116242
18.
Antibody production by the gram-positive bacterium Bacillus megaterium.
Methods Mol Biol
; 525: 509-16, xiv, 2009.
Article
in English
| MEDLINE | ID: mdl-19252842
19.
Affinity maturation by phage display.
Methods Mol Biol
; 525: 309-22, xv, 2009.
Article
in English
| MEDLINE | ID: mdl-19252854
20.
Short chain regioselectively hydrolyzed scleroglucans induce maturation of porcine dendritic cells.
Appl Microbiol Biotechnol
; 82(2): 321-31, 2009 Feb.
Article
in English
| MEDLINE | ID: mdl-19107473